Back

Tralokinumab: A review on its efficacy, safety, and tolerability in treatment of atopic dermatitis

Summaries 6 min 761

Font Size

Created On: 21/07/2021

Tralokinumab: A review on its efficacy, safety, and tolerability in treatment of atopic dermatitis

Tralokinumab: A review on its efficacy, safety, and tolerability in treatment of atopic dermatitis

Tralokinumab: A review on its efficacy, safety, and tolerability in treatment of atopic dermatitis

Tralokinumab: A review on its efficacy, safety, and tolerability in treatment of atopic dermatitis

Atopic dermatitis (or eczema) is one of the most common heterogeneous inflammatory skin diseases.

See All

Attachment

Previous

Next
Risk assessment of rituximab usage and COVID-19 infection in patients with MS and NMOSD

Comments (0)

Read

Watch

Russia’s N protein-based vaccine emerges as strong contender in g...

Can tocotrienol-rich vitamin E improve NAFLD in obese children?

COVID-19 and GI symptoms: Is H. pylori infection the missing link...

Read- How poor antibiotic knowledge fuels unnecessary demand in p...

Efficacy and safety of nonsteroidal anti-inflammatory drugs in As...

An introduction to pain pathways and mechanisms

Thank you for your participation!

Association between pain, central sensitization and anxiety in po...

Related Content

Next

Big Card Banner

Big Card Banner

Summaries

Risk assessment of rituximab usage and COVID-19 infection in pati...

Selecting a safe disease modifying therapy (DMT) during the COVID-19 is perplexing. This analytical case series study was aimed to find the incid...

3 min More details